Gefticip Tablet

Welcome to the information page for Gefticip Tablet, brought to you by Cipla Ltd. This product contains the active ingredient Gefitinib (250mg) and is indicated for Non-small cell lung cancer. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 5491.72
Packing: 30.0 tablets in 1 strip
Salt Combination: Gefitinib (250mg)
Brand: Cipla Ltd
Uses: Non-small cell lung cancer

Description

Gefticip Tablet is used in the treatment of non-small cell lung cancer
It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer
Gefticip Tablet should be taken in a dose as recommended by the doctor
You should continue to take it as long as your doctor advises for it
The duration of treatment varies according to your need and response to treatment
Your doctor may advice for regular monitoring of liver function while your taking this medicine.
Common side effects include diarrhea, dry skin, loss of appetite, and nausea
Drink plenty of fluids to reduce the risk of side effects
Inform your doctor if any of the side effects bother you or get worse
In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor.
Women who are undergoing treatment should use effective contraception method
It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine
Let your doctor also know about all the other medications you are taking.

Cautions

Liver:	SAFE IF PRESCRIBED: Gefticip Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefticip Tablet may not be needed in these patients. Please consult your doctor.
Kidney:	CAUTION: Gefticip Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Gefticip Tablet may be needed. Please consult your doctor.
Driving:	UNSAFE: Gefticip Tablet may cause side effects which could affect your ability to drive.
Breast feeding:	CONSULT YOUR DOCTOR: Gefticip Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	CONSULT YOUR DOCTOR: Gefticip Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	UNSAFE: It is unsafe to consume alcohol with Gefticip Tablet.
Drug Action:	Tyrosine kinase inhibitors
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Quinazolinamines

Uses of Gefticip Tablet

In Non-small cell lung cancer Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers
Gefticip Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines
It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor
You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.